Stay updated on Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', signaling that the study is not recruiting. New help and navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), along with a formatting change to the Intervention/Treatment heading and a page revision tag (Revision: v3.6.0).SummaryDifference0.2%

- Check20 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a small internal update to the page framework; no user-facing content changes are shown.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, representing a new published version of the page.SummaryDifference0.0%

- Check56 days agoChange DetectedThe Taiwan site location was updated to Taoyuan County, Taiwan, replacing the previous Taoyuan entry to reflect the correct administrative region for that study site.SummaryDifference0.0%

- Check63 days agoChange DetectedClinicalTrials.gov’s page footer revision/version label was updated from v3.5.2 to v3.5.3, reflecting a platform/version change rather than a change to the NCT study information.SummaryDifference0.0%

- Check70 days agoChange DetectedUpdated the collaborator name to Ono Pharmaceutical Co., Ltd. and revised the document version from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page.